Litigation Details for Sun Pharmaceutical Industries Ltd. v. Saptalis Pharmaceuticals, LLC (D. Del. 2018)

Docket	⤷ Start Trial	Date Filed	2018-04-30
Court	District Court, D. Delaware	Date Terminated	2019-09-04
Cause	35:271 Patent Infringement	Assigned To	William C. Bryson
Jury Demand	None	Referred To
Parties	RANBAXY SIGNATURE, LLC
Patents	6,890,957
Attorneys	Charles B. Klein
Firms	Heyman Enerio Gattuso & Hirzel LLP
Link to Docket	External link to docket

The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-04-30				External link to document
2018-04-30	108	Order - -Memorandum and Order	LLC, is the sole owner of U.S. Patent No. 6,890,957 (“the ’957 patent”). Dkt. No. 1, at 3. Plaintiff …Compare ‘957 patent, claim 3 with ’957 patent, claim 4. Saptalis argues that because the patent contains…application that issued as U.S. Patent No. 6,559,187 (“the ’187 patent”). See Dkt. No. 70, at 2; Dkt. …diabetes.” ’957 patent, col. 1, ll. 15–17. Claim 1 is the only independent claim of the ’957 patent. Dkt. No…the drug protected by the ’957 patent. The agency then listed the patent in its publication entitled Approved	External link to document
2018-04-30	149	Judgment	not infringe any asserted claim of U.S. Patent No. 6,890,957. Thus, judgment of noninfringement is entered… counterclaim, asserting invalidity of the ’957 patent, the parties argue that the claim is moot in light… 4 September 2019 1:18-cv-00648 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document